Companies Cryptocurrencies
Pacira Biosciences Inc
Pacira Biosciences Inc
Exchange: Nasdaq Global Select
IPO Date: 03/02/2011
CEO: Mr. David Stack
Drug Manufacturers General Specialty & Generic Healthcare 🔗
  • PCRX
  • 58.3
  • 2648965376
    market cap
  • -0.33000183
If you bought

shares of Pacira Biosciences Inc (PCRX) on
You would have made
Old Price $12 Current Price $12

Pacira Biosciences, Inc. develops and manufactures injectable therapeutic products. The company is headquartered in Parsippany, New Jersey and currently employs 518 full-time employees. The firm is a pharmaceutical company focused on the development, manufacture and commercialization of pharmaceutical products, based on its DepoFoam extended release drug delivery technology, for use primarily in hospitals and ambulatory surgery centers. Its lead product candidate is EXPAREL (bupivacaine liposome injectable suspension), which consists of bupivacaine, an amide-type local anesthetic, encapsulated in DepoFoam and is indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. In addition to EXPAREL, DepoFoam is also the basis for its other Food and Drug Administration-approved commercial product, DepoCyt(e), which it manufactures for its commercial partners, as well as its product candidates. The firm’s other product candidates include DepoMeloxicam (DepoMLX) and DepoTranexamic Acid (DepoTXA).

Address: 5 Sylvan Way Ste 300 Parsippany NEW JERSEY 07054

Stay updated.